AB0860 the Predictors for 24 Months Efficacy of Denosumab, an ANTI-RANKL Antibody, on Osteoporosis in Patients With Rheumatoid Arthritis From Multicenter Study (TBCR-BONE)
doi 10.1136/annrheumdis-2017-eular.3938
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism